MASS DIETHYLCARBAMAZINE CHEMOTHERAPY FOR CONTROL OF BANCROFTIAN FILARIASIS - COMPARATIVE EFFICACY OF STANDARD TREATMENT AND 2 SEMIANNUAL SINGLE-DOSE TREATMENTS
Dw. Meyrowitsch et al., MASS DIETHYLCARBAMAZINE CHEMOTHERAPY FOR CONTROL OF BANCROFTIAN FILARIASIS - COMPARATIVE EFFICACY OF STANDARD TREATMENT AND 2 SEMIANNUAL SINGLE-DOSE TREATMENTS, Transactions of the Royal Society of Tropical Medicine and Hygiene, 90(1), 1996, pp. 69-73
Citations number
20
Categorie Soggetti
Public, Environmental & Occupation Heath","Tropical Medicine
The efficacy of 2 strategies for control of bancroftian filariasis usi
ng mass diethylcarbamazine (DEC) chemotherapy was evaluated and compar
ed in 2 endemic communities in Tanzania with pre-treatment microfilari
al (mf) prevalences of 28.5% and 17.7%, and mf geometric mean intensit
ies (GMI) of 588 mf/mL and 251 mf/mL, respectively. All individuals in
the first community were offered DEC treatment with 6 mg/kg body weig
ht given daily for 12 d (standard treatment). The second community was
offered DEC treatment with 2 single doses of 6 mg/kg body weight give
n with an interval of 6 months (semi-annual single-dose treatment). Am
ong those who were microfilaraemic before treatment, the mf clearance
rates were 51.2% and 36.0%, and the mf GMIs were reduced by 98.6% and
92.2% one year after the start of the standard and the semi-annual reg
imens, respectively. At community level, the standard strategy and the
semi-annual strategy reduced the mf prevalences to 15.1% and 11.6% (r
eductions of 47.0% and 34.5%) and the mf GMIs to 112 mf/mL and 102 mf/
mL (reductions of 81.0% and 59.4%, respectively) one year after start
of treatment. Both regimens resulted in remarkable improvements in sma
ll hydroceles among males presenting this condition before treatment.
The lower efficacy of the semi-annual single-dose treatment in relatio
n to the standard treatment in reducing microfilaraemias might be comp
ensated for by continuing semi-annual treatments for a slightly longer
period of time. Considering that the semi-annual treatment is easy to
administer and more acceptable to the treated individuals, it may in
the long run be a more feasible strategy for mass DEC chemotherapy tha
n the standard treatment.